- Home
- ARL vs CMPX Comparison
ARL vs CMPX Comparison
Compare ARL & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- CMPX
- Stock Information
- Founded
- ARL 1999
- CMPX 2014
- Country
- ARL United States
- CMPX United States
- Employees
- ARL N/A
- CMPX N/A
- Industry
- ARL Building operators
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- ARL Real Estate
- CMPX Health Care
- Exchange
- ARL Nasdaq
- CMPX Nasdaq
- Market Cap
- ARL 233.2M
- CMPX 291.8M
- IPO Year
- ARL N/A
- CMPX N/A
- Fundamental
- Price
- ARL $12.95
- CMPX $3.05
- Analyst Decision
- ARL
- CMPX Strong Buy
- Analyst Count
- ARL 0
- CMPX 9
- Target Price
- ARL N/A
- CMPX $12.67
- AVG Volume (30 Days)
- ARL 4.3K
- CMPX 727.6K
- Earning Date
- ARL 08-07-2025
- CMPX 08-11-2025
- Dividend Yield
- ARL N/A
- CMPX N/A
- EPS Growth
- ARL N/A
- CMPX N/A
- EPS
- ARL N/A
- CMPX N/A
- Revenue
- ARL $48,234,000.00
- CMPX $850,000.00
- Revenue This Year
- ARL N/A
- CMPX N/A
- Revenue Next Year
- ARL N/A
- CMPX N/A
- P/E Ratio
- ARL N/A
- CMPX N/A
- Revenue Growth
- ARL N/A
- CMPX N/A
- 52 Week Low
- ARL $9.43
- CMPX $0.87
- 52 Week High
- ARL $22.77
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- ARL 42.97
- CMPX 56.85
- Support Level
- ARL $12.90
- CMPX $3.11
- Resistance Level
- ARL $14.38
- CMPX $3.26
- Average True Range (ATR)
- ARL 0.68
- CMPX 0.21
- MACD
- ARL -0.05
- CMPX -0.01
- Stochastic Oscillator
- ARL 21.50
- CMPX 50.92
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.